FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
On April 1, 2020, the U.S. Food and Drug Administration requested the immediate market removal of all prescription and over-the-counter ranitidine products (Zantac) in the face of alarming data linking ranitidine use to cancer. Testing of some ranitidine medications showed unsafe levels of N-Nitrosodimethylamine (NDMA), a substance known to cause cancer. According to the FDA, NDMA in certain ranitidine medications “increases over time and when stored at higher-than-normal temperatures and may result in consumer exposure to unacceptable levels…”
Ranitidine, commonly known by its brand name Zantac, is a popular antacid medication, available over-the-counter and by prescription, commonly used to treat ulcers, acid reflux, heartburn, and various other medical conditions since the 1980’s. If you or a loved one has developed cancer after taking Zantac or another medication containing ranitidine, you may be entitled to compensation. We encourage you to contact Wise Law right away to speak with an experienced attorney who can help you learn more about your legal options.